Hyderabad: Wockhardt Ltd is recalling 109,744 bottles of anti-hypertensive drug belonging to multiple lots from the American market following failure of dissolution test, US regulator FDA said. According to a notification by the USFDA, the recall is voluntarily and was initiated by the company from April 1 under ‘Class-II’ classification. The recall of metoprolol is a generic version of AstraZeneca Plc’s branded drug Toprol.
Wockhardt recalls hypertension drug in US
RECENT STORIES
Central Government's Fiscal Deficit Touches 52.6% Of The Full-Year Target
Sudeep Pharma's Shares End With A 30.54% Premium Against The Issue Price Of ₹593
From 'Nimbu Pani' To 'Narasimha Avatar': Lakshmi Iyer’s Guide To The 'Decadal Journey' Of...
India Pins Hopes On Slow-Moving Framework Trade Deal With The US, Tariff Issue To Swell During Talks...
CEA Nageswaran Slams Concentration Of Large & Well-Rated Companies In The Bond Market, Mid-Sized...